LON:INDV Indivior (INDV) Share Price, News & Analysis → Bigger Than NVIDIA? (From Behind the Markets) (Ad) Free INDV Stock Alerts GBX 1,279 -2.00 (-0.16%) (As of 07:56 AM ET) Add Compare Share Share Today's Range 1,270▼ 1,29150-Day Range 1,278.11▼ 1,63252-Week Range 1,125▼ 1,938Volume126,854 shsAverage Volume406,147 shsMarket Capitalization£1.73 billionP/E Ratio42,633.33Dividend Yield1.17%Price TargetGBX 2,700 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Get Indivior alerts: Email Address Indivior MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside111.1% UpsideGBX 2,700 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingSelling Shares£17.06 M Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.38 out of 5 stars 2.0 Analyst's Opinion Amount of Analyst CoverageIndivior has received no research coverage in the past 90 days.Read more about Indivior's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for INDV. Previous Next 1.7 Dividend Strength Dividend LeadershipIndivior is a leading dividend payer. It pays a dividend yield of 4.48%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthIndivior does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Indivior is 50,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Indivior's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INDV. Previous Next 0.6 News and Social Media Coverage Search Interest1 people have searched for INDV on MarketBeat in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Indivior insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £170,577.33 in company stock.Percentage Held by InsidersOnly 3.25% of the stock of Indivior is held by insiders.Percentage Held by Institutions85.55% of the stock of Indivior is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Indivior's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Indivior is 42,633.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 139.45.Price to Earnings Ratio vs. SectorThe P/E ratio of Indivior is 42,633.33, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 160.04.Price to Earnings Growth RatioDue to a projected decrease in earnings for Indivior, their PEG ratio cannot be calculated.Price to Book Value per Share RatioIndivior has a P/B Ratio of 182.71. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsWill this AI Micro-Cap be Bigger than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout AI stock. But right now... There's only ONE AI stock you should be watching.Get the full story here >>> About Indivior Stock (LON:INDV)Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder. The company also offers OPVEE nasal spray for opioid overdose reversal; and PERSERIS extended-release injectable suspension for the treatment of schizophrenia in adults. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that completed phase 1 clinical trial for the treatment of opioid use disorder (OUD); INDV-1000, a selective GABAb positive allosteric modulator, which is in pre-clinical development phase for the treatment of alcohol use disorder in collaboration with ADDEX therapeutics; INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc.; and CT-102, a digital therapeutic for the treatment of OUD in collaboration with Click Therapeutics. Further, the company is developing INDV-5004, a drinabant injection to treat acute cannabinoid overdose. It has a strategic partnership with Aelis Farma to develop AEF0117, a synthetic CB1 specific signaling inhibitor that is in phase 2B clinical trial for the treatment of cannabis use disorder. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.Read More INDV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INDV Stock News HeadlinesMay 23, 2024 | marketwatch.comIndivior Shareholders Approve Main Listing Switch to U.S.May 1, 2024 | lse.co.ukLondon open: FTSE edges higher ahead of Fed; Nationwide data in focusApril 26, 2024 | finance.yahoo.comWhy Indivior PLC (LON:INDV) Looks Like A Quality CompanyApril 14, 2024 | nasdaq.comNotable Two Hundred Day Moving Average Cross - INDVMarch 12, 2024 | msn.comThis Nasal Spray Rapidly Reverses Effects Of Fentanyl Overdose And No, It's Not NaloxoneFebruary 29, 2024 | markets.businessinsider.comIndivior Says Final Court Approval Concludes Antitrust Multidistrict LitigationFebruary 24, 2024 | reuters.comEurope's STOXX 600 at all-time high as Nvidia boosts global tech sharesFebruary 22, 2024 | msn.comIndivior weighs moving primary listing to U.S.February 10, 2024 | finance.yahoo.comIndivior PLC (LON:INDV) Shares Could Be 44% Below Their Intrinsic Value EstimateJanuary 18, 2024 | markets.businessinsider.comAdial Announces Appointment of Tony Goodman as Chief Operating OfficerNovember 20, 2023 | finance.yahoo.comGreat week for Indivior PLC (LON:INDV) institutional investors after losing 22% over the previous yearNovember 9, 2023 | msn.comIndivior PLC (INDV) Tops Q3 Earnings and Revenue EstimatesOctober 2, 2023 | finance.yahoo.comIndivior PLC (INDV): Unveiling Its Market ValueSeptember 26, 2023 | finance.yahoo.comIndivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in CanadaSeptember 7, 2023 | finance.yahoo.comIndivior PLC (INDV)'s True Worth: A Complete Analysis of Its Market ValueJune 12, 2023 | finance.yahoo.comThe 7.5% return this week takes Indivior's (LON:INDV) shareholders three-year gains to 372%June 12, 2023 | finance.yahoo.comIndivior to Commence Trading on NasdaqJune 7, 2023 | msn.comJefferies Reiterates Indivior (LSE:INDV) Buy RecommendationJune 5, 2023 | reuters.comIndivior opioid settlement makes purer M&A caseJune 3, 2023 | msn.comUS drugmaker Indivior to pay $102.5 million to settle Suboxone monopoly claimsJune 2, 2023 | finanznachrichten.deIndivior PLC: Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation ClaimsMay 25, 2023 | uk.finance.yahoo.comINDV.L - Indivior PLCMay 25, 2023 | finance.yahoo.comIndivior To Participate In Upcoming Investor ConferencesMay 23, 2023 | finance.yahoo.comIndivior PLC Form 20-F Registration Statement for Additional US Listing Now Available; Trading on NASDAQ Expected to Commence on June 12thMay 22, 2023 | markets.businessinsider.comFDA Approves Opiant's Nasal Spray 'Opvee' To Reverse Opioid OverdoseSee More Headlines Receive INDV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolLON:INDV CUSIPN/A CIKN/A Webindivior.com Phone+44-1753-217800FaxN/AEmployees1,000Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 2,700 High Stock Price TargetGBX 2,700 Low Stock Price TargetGBX 2,700 Potential Upside/Downside+110.8%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.03 Trailing P/E Ratio42,700.00 Forward P/E Ratio1,208.49 P/E Growth-5.57Net Income£5 million Net Margins0.44% Pretax MarginN/A Return on Equity12.20% Return on Assets9.94% Debt Debt-to-Equity Ratio2,790.00 Current Ratio0.93 Quick Ratio1.52 Sales & Book Value Annual Sales£1.12 billion Price / Sales1.55 Cash FlowGBX 477.97 per share Price / Cash Flow2.68 Book ValueGBX 7 per share Price / Book183.00Miscellaneous Outstanding Shares135,140,000Free FloatN/AMarket Cap£1.73 billion OptionableNot Optionable Beta0.06 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Mark CrossleyCEO & Executive DirectorMr. Ryan PreblickCFO & Executive DirectorDr. Christian HeidbrederChief Scientific OfficerMr. Jason ThompsonVice President of Investor RelationsMs. Cynthia CetaniChief Integrity & Compliance OfficerMr. Jeffrey W. Burris (Age 52)Chief Legal Officer Mr. Jon FogleChief Human Resources OfficerMr. Richard SimkinChief Commercial OfficerMr. Hillel WestChief Manufacturing & Supply OfficerMr. Vishal KaliaSVP of US Treatment Access, Support Programs & Business Insights and Chief Impact & Strategy OfficerMore ExecutivesKey CompetitorsHikma PharmaceuticalsLON:HIKHUTCHMEDLON:HCMAmryt PharmaLON:AMYTBenchmarkLON:BMKAllergy TherapeuticsLON:AGYView All CompetitorsInsidersMark CrossleySold 10,549 sharesTotal: £17.06 M ($1,617.00/share)Mark CrossleySold 15,444 sharesTotal: £25.39 M ($1,644.00/share)Graham HetheringtonBought 1,743 shares on 12/20/2023Total: £2.07 M ($1,189.00/share)Graham HetheringtonBought 2,650 shares on 11/20/2023Total: £3.58 M ($1,350.00/share)View All Insider Transactions INDV Stock Analysis - Frequently Asked Questions What is Indivior's stock price target for 2024? 0 Wall Street analysts have issued 12 month price targets for Indivior's shares. Their INDV share price targets range from GBX 2,700 to GBX 2,700. On average, they anticipate the company's share price to reach GBX 2,700 in the next twelve months. This suggests a possible upside of 111.1% from the stock's current price. View analysts price targets for INDV or view top-rated stocks among Wall Street analysts. How have INDV shares performed in 2024? Indivior's stock was trading at GBX 1,185 at the beginning of the year. Since then, INDV stock has increased by 7.9% and is now trading at GBX 1,279. View the best growth stocks for 2024 here. Is Indivior a good dividend stock? Indivior (LON:INDV) pays an annual dividend of GBX 15 per share and currently has a dividend yield of 4.48%. INDV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 50,000.00%. Payout ratios above 75% are not desirable because they may not be sustainable. What other stocks do shareholders of Indivior own? Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Bigblu Broadband (BBB), Futura Medical (FUM), Directa Plus (DCTA), Lakehouse (LAKE), Aquila Services Group (AQSG), Benchmark (BMK), Bodycote (BOY), CityFibre Infrastructure (CITY), Deltex Medical Group (DEMG) and Kingfisher (KGF). How do I buy shares of Indivior? Shares of INDV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:INDV) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indivior PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Indivior With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.